Vancomycin-resistant enterococci

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1196-1199

  Moellering Jr , Robert C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; NITROFURANTOIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ENTEROCOCCUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; UNITED STATES; URINARY TRACT INFECTION;

EID: 17344365611     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520283     Document Type: Article

References (29)

1. Murray BE. Can antibiotic resistance be controlled? N Engl J Med 1994;330:1229-30.
2. Woodford N, Johnson AP, Morrison D, Speller DCE. Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995;8:585-615.
3. Arthur M, Reynolds PE, Depardieu F, et al. Mechanisms of glycopeptide resistance in enterococci. J Infect Dis 1996;32:11-6.
4. Ena J, Dick RW, Jones R, Wenzel, RP. The epidemiology of intravenous vancomycin usage in a university hospital. JAMA 1993;269:598-602.
5. Moellering RC Jr. Enterococcus species, Streptococcus bovis and Leuconostoc. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious disease. 4th ed. New York: Churchill Livingstone, 1995:1826-35.
6. Schaberg DG, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(suppl 3B):72S-5S.
7. Moellering RC Jr, Krogstad DJ. Antibiotic resistance in enterococci. In: Schlessinger D, ed. Microbiology - 1979. Washington, DC: American Society for Microbiology, 1979:293-8.
8. Hodges TR, Zighelboim-Daum S, Eliopoulus GM, Wennersten CB, Moellering RC Jr. Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens. Antimicrob Agents Chemother 1992;36:121-5.
9. Grayson ML, Eliopoulos GM, Wennersten CB, et al. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 1991;35:2180-4.
10. Gold HS, Moellering RC Jr. Drug therapy: antimicrobial-drug resistance. N Engl J Med 1996;335:1445-54.
11. Quintiliani R, Evers S, Courvalin P. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis 1993;167:1220-3.
12. Perichon B, Reynolds PE, Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium [abstract no LB12]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996 (Addendum), p. 5.
13. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993;42:597-9.
14. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 1993;37:2311-7.
15. Rubin LG, Tucci V, Cercenado E, Eliopoulos GM, Isenberg HD. Vancomycin resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-5.
16. Boyle JF, Saumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characteristic of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280-5.
17. Handwerger S, Skoble J, Discotto LF, Pucci MJ. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States. Antimicrob Agents Chemother 1995;39:362-8.
18. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multi drug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
19. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-33.
20. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995;21:45-50.
21. O'Donovan CA, Fan-Habard P, Tecson-Tumang FT, Smith SM, Eng RHK. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994;18:105-9.
22. LeClercq R, Bingen E, Su QH, Lambert-Zechovski N, Courvlin P, Duval J. Effects of combinations of β-lactams, daptomycin, gentamicin and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother 1991;35:92-8.
23. Zighelboim-Daum S, Moellering RC Jr. Mechanisms and significance of antimicrobial resistance in enterococci. In: Actor P, Daneo-Moore L, Higgins ML, Salton MRJ, Shockman GD, eds. Antibiotic inhibition of bacterial cell surface assembly and function. Washington, DC: American Society for Microbiology, 1988:603-25.
24. Caron F, Lemeland JF, Humbert G, Klare I, Gutmann L. Triple combinations of penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin and glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis 1993;168:681-6.
25. Feldman RJ, Paul SM, Silber JL, Cody RP, Noveck H, Weinstein MP. An analysis of treatment of patients with vancomycin-resistant enterococcal bacteremia. Infect Dis Clin Prac 1996;5:440-5.
26. Moellering RC Jr, Cerwinka SL. Early clinical results with quinupristindalfopristin for the therapy of bacteremia due to resistant gram-positive bacteria. In: Zinner S, Young L, Acar J, Neu H, eds. New macrolides, azalides, streptogramins in clinical practice (ICMAS III). New York: M. Dekker, 1997:173-6.
27. Biavasco F, Giovanetti E, Miele A, Vignaroli C, Facinelli B, Varaldo PE. In vitro conjugative transfer of VanA vancomycin resistance between enterococci and listeriae of different species. Eur J Clin Microbiol Infect Dis 1996;15:50-9.
28. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992;93:195-8.
29. Poyart C, Pierre C, Quesne G, et al. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a VanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother 1997;41:24-9.